Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Sunitinib-Induced Myeloid Lineage Redistribution in Renal Cell Cancer Patients: CD1c+ Dendritic Cell Frequency Predicts Progression-Free Survival
2008
Decision Curve Analysis: A Novel Method for Evaluating Prediction Models
2006 Standout
The clinical symptoms of Parkinson's disease
2016 Standout
Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial
2007 Standout
Bias in random forest variable importance measures: Illustrations, sources and a solution
2007 Standout
A phase I/II study of siltuximab (CNTO 328), an anti-interleukin-6 monoclonal antibody, in metastatic renal cell cancer
2010
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD statement
2015 Standout
FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis
2010 StandoutNobel
Serum-Soluble B7x Is Elevated in Renal Cell Carcinoma Patients and Is Associated with Advanced Stage
2008 StandoutNobel
Autologous Bone Marrow–Derived Cultured Mesenchymal Stem Cells Delivered in a Fibrin Spray Accelerate Healing in Murine and Human Cutaneous Wounds
2007
EGFR Antagonists in Cancer Treatment
2008 Standout
Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement
2015 Standout
Do Prognostic Parameters of Remission versus Relapse after Bacillus Calmette–Guérin (BCG) Immunotherapy Exist? Analysis of a Quarter Century of Literature
2003
Repeat Transurethral Resection in Non–muscle-invasive Bladder Cancer: A Systematic Review
2018
Fuhrman Grading is not Appropriate for Chromophobe Renal Cell Carcinoma
2007
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
2008 Standout
Towards better clinical prediction models: seven steps for development and an ABCD for validation
2014 Standout
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Prognostic markers in renal cell carcinoma
2007
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Minimally invasive adrenal surgery: an update
2011
A Critical Analysis of Surgery for Kidney Cancer with Vena Cava Invasion
2007
Renal Cell Carcinoma Guideline
2007
The rising prevalence of androgen deprivation among older American men since the advent of prostate‐specific antigen testing: a population‐based cohort study
2006
Clinical development and potential of photothermal and photodynamic therapies for cancer
2020 Standout
Is There a Need to Further Subclassify pT2 Renal Cell Cancers as Implemented by the Revised 7th TNM Version?
2010
Selenium and prostate cancer: systematic review and meta-analysis
2012
Cushing's syndrome
2015 Standout
Nomograms in oncology: more than meets the eye
2015 Standout
Modulation of oxidative stress as an anticancer strategy
2013 Standout
Coordinated regulation of myeloid cells by tumours
2012 Standout
Predicting outcomes in radiation oncology—multifactorial decision support systems
2012
Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Solid Tumors: A Systematic Review and Meta-Analysis
2014 Standout
Long-Term Mortality after Gastric Bypass Surgery
2007 Standout
Selenium and human health
2012 Standout
Intake of Selenium in the Prevention of Prostate Cancer: a Systematic Review and Meta-analysis*
2005
Machine Learning methods for Quantitative Radiomic Biomarkers
2015 Standout
External Validation of the Mayo Clinic Stage, Size, Grade, and Necrosis (SSIGN) Score for Clear-Cell Renal Cell Carcinoma in a Single European Centre Applying Routine Pathology
2008
Insulin and insulin-like growth factor signalling in neoplasia
2008 Standout
The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia
2013
Urinary tract dysfunction in Parkinson’s disease: a review
2011
C-reactive protein as a biomarker for urological cancers
2011
EAU Guidelines on Renal Cell Carcinoma: The 2010 Update
2010
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
2006 Standout
Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers
2010 Standout
Increased Risk of High-Grade Hypertension With Bevacizumab in Cancer Patients: A Meta-Analysis
2010
Targeting the IL-6/JAK/STAT3 signalling axis in cancer
2018 Standout
Introduction to small renal tumours and prognostic indicators
2016
Current Pathology Keys of Renal Cell Carcinoma
2011
Are men with low selenium levels at increased risk of prostate cancer?
2006
Bladder cancer
2016 Standout
PTEN loss of expression predicts cetuximab efficacy in metastatic colorectal cancer patients
2007
The VHL/HIF axis in clear cell renal carcinoma
2012 StandoutNobel
FOXO1 and TCF7L2 genes involved in metastasis and poor prognosis in clear cell renal cell carcinoma
2010
A Review of Integrated Staging Systems for Renal Cell Carcinoma
2012
Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy
2013
Epidemiology and pathophysiology of obesity as cause of cancer
2007
Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies
2008 Standout
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Chromophobe Renal Cell Carcinoma: Histomorphologic Characteristics and Evaluation of Conventional Pathologic Prognostic Parameters in 145 Cases
2008
Influence of Body Mass Index on Prognosis of Japanese Patients with Renal Cell Carcinoma
2007
Assessing the Performance of Prediction Models
2009 Standout
EAU Guidelines on Renal Cell Carcinoma: 2014 Update
2015 Standout
Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis
2008
Prognostic Factors and Predictive Models in Renal Cell Carcinoma: A Contemporary Review
2011
The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours
2016 Standout
Risk of hypertension in cancer patients treated with sorafenib: an updated systematic review and meta-analysis
2013
Nonmetastatic renal-cell carcinoma: is it really possible to define rational guidelines for post-treatment follow-up?
2006
Tumor classification by tissue microarray profiling: random forest clustering applied to renal cell carcinoma
2004
Cancer-related inflammation and treatment effectiveness
2014 Standout
A Preoperative Prognostic Model for Patients Treated with Nephrectomy for Renal Cell Carcinoma
2008
Renal cell carcinoma
2017 Standout
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Photodynamic Diagnosis of Non–muscle-invasive Bladder Cancer with Hexaminolevulinate Cystoscopy: A Meta-analysis of Detection and Recurrence Based on Raw Data
2013
Radiomics: the bridge between medical imaging and personalized medicine
2017 Standout
HIF activation causes synthetic lethality between the VHL tumor suppressor and the EZH1 histone methyltransferase
2017 StandoutNobel
Wound repair and regeneration: Mechanisms, signaling, and translation
2014 Standout
How To Build and Interpret a Nomogram for Cancer Prognosis
2008 Standout
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
2012 Standout
Membranous expression and prognostic implications of epidermal growth factor receptor protein in human renal cell cancer.
2005
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma
2006
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): Explanation and Elaboration
2015 Standout
The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial
2006
The Chromophobe Tumor Grading System is the Preferred Grading Scheme for Chromophobe Renal Cell Carcinoma
2011
Bladder Cancer
2020 Standout
Evaluation of Urine Aquaporin-1 and Perilipin-2 Concentrations as Biomarkers to Screen for Renal Cell Carcinoma
2015
Prostate Specific Antigen Best Practice Statement: 2009 Update
2009
Phase I Trial of Bevacizumab Plus Escalated Doses of Sunitinib in Patients With Metastatic Renal Cell Carcinoma
2009
Multi-Institutional Validation of a New Renal Cancer–Specific Survival Nomogram
2007
The R.E.N.A.L. Nephrometry Score: A Comprehensive Standardized System for Quantitating Renal Tumor Size, Location and Depth
2009 Standout
Independent Validation of the 2010 American Joint Committee on Cancer TNM Classification for Renal Cell Carcinoma: Results From a Large, Single Institution Cohort
2011
Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD): The TRIPOD Statement
2015 Standout
Guideline for Management of the Clinical T1 Renal Mass
2009 Standout
Smoking and Overweight: Negative Prognostic Factors in Stage III Epithelial Ovarian Cancer
2006
Photothermal Nanomaterials: A Powerful Light-to-Heat Converter
2023 Standout
The Role of the IGF System in Cancer Growth and Metastasis: Overview and Recent Insights
2007
Comparison of MR/Ultrasound Fusion–Guided Biopsy With Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer
2015 Standout
Works of Luigi Schips being referenced
Proposal for revision of the TNM classification system for renal cell carcinoma
2005
Impact of tumor-associated symptoms on the prognosis of patients with renal cell carcinoma: a single-center experience of 683 patients
2003
Validation by calibration of the UCLA integrated staging system prognostic model for nonmetastatic renal cell carcinoma after nephrectomy
2008
Autologous Fibrin Glue Using the Vivostat System for Hemostasis in Laparoscopic Partial Nephrectomy
2006
Patients with renal cell carcinoma nodal metastases can be accurately identified: External validation of a new nomogram
2007
Are heterogenous results of EGFR immunoreactivity in renal cell carcinoma related to non-standardised criteria for staining evaluation?
2004
Does overweight impact on the prognosis of patients with renal cell carcinoma? A single center experience of 683 patients
2004
Serum Levels of Vascular Endothelial Growth Factor (VEGF) and Endostatin in Renal Cell Carcinoma Patients Compared to a Control Group
2006
Renal Cell Carcinoma with Nodal Metastases in the Absence of Distant Metastatic Disease: Prognostic Indicators of Disease-Specific Survival
2006
Keratin immunohistochemistry in renal cell carcinoma subtypes and renal oncocytomas: a systematic analysis of 233 tumors
2004
Prognostic Relevance of Tumour Size in T3a Renal Cell Carcinoma: A Multicentre Experience
2007
Selenium levels of patients with newly diagnosed prostate cancer compared with control group
2004
Detection of prostate cancer by TURP or open surgery in patients with previously negative transrectal prostate biopsies
2003
Relationship between Age at Diagnosis and Clinicopathologic Features of Renal Cell Carcinoma
2006
Did the rate of incidental prostate cancer change in the era of PSA testing? A retrospective study of 1127 patients
2003
Chromophobe renal cell carcinoma: Comprehensive analysis of 104 cases from multicenter European database
2005
Expression of MUC1 (EMA) and E-cadherin in renal cell carcinoma: a systematic immunohistochemical analysis of 188 cases
2004
A comparison of hexaminolevulinate (Hexvix®) fluorescence cystoscopy and white-light cystoscopy for detection of bladder cancer: results of the HeRo observational study
2012
Is repeated transurethral resection justified in patients with newly diagnosed superficial bladder cancer?
2002
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram
2007
Value of p53 as a prognostic marker in histologic subtypes of renal cell carcinoma: a systematic analysis of primary and metastatic tumor tissue
2004
Multiinstitutional European validation of the 2002 TNM staging system in conventional and papillary localized renal cell carcinoma
2005
Analysis of Insulin-like Growth Factors and Insulin-like Growth Factor I Receptor Expression in Renal Cell Carcinoma
2004
Comparison of predictive accuracy of four prognostic models for nonmetastatic renal cell carcinoma after nephrectomy
2005
Assessing Feasibility and Safety of Laparoendoscopic Single-Site Surgery Adrenalectomy: Initial Experience
2010
Analysis of Insulin-Like Growth Factors and Insulin-Like Growth Factor I Receptor Expression in Renal Cell Carcinoma
2004
Steroid Hormone Receptor Expression in Renal Cell Carcinoma: An Immunohistochemical Analysis of 182 Tumors
2004
546 PROGNOSIS VALUE OF RENAL VEIN (RV) AND INFERIOR VENA CAVA (IVC) INVOLVEMENT IN RENAL CELL CARCINOMA (RCC)
2007
A New Staging System for Locally Advanced (pT3–4) Renal Cell Carcinoma: A Multicenter European Study Including 2,000 Patients
2007
740: Can PT2 Classification for Renal Cell Carcinoma be Improved? an International Multicenter Experience?
2006